Form 4 for CNMD CONMED Corp
Accepted 2026-03-10 00:00:00 ET · period of report 2026-03-06 · accession 0000816956-26-000029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-10 | 2026-03-06 | CNMD | Lalomia Brent | Executive VP RA, QA | F - Tax | $39.90 | -26 | 915.06 | -3% | -$1,037 |
| D | 2026-03-10 | 2026-03-06 | CNMD | Lalomia Brent | Executive VP RA, QA | M - OptEx | $0.00 | +75 | 941.06 | +9% | $0 |
| D | 2026-03-10 | 2026-03-06 | CNMD | Lalomia Brent | Executive VP RA, QA | M - OptEx | $0.00 | -75 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-06 | F | D | 26 | $39.90 | 915.06 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-06 | M | A | 75 | $0.00 | 941.06 | D | — | — | (F1) The number of shares beneficially owned by the reporting person has been adjusted to exclude 140 shares that were incorrectly reflected in prior reports. |
| 3 | Derivative | RSUs (Restricted Stock Units) | 2026-03-06 | M | D | 75 | $0.00 | 0 | D | $0.00 · — to 2032-03-07 | 75 Common Stock | (F2) Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each RSU represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation. |